Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
06 2023
Historique:
received: 13 03 2023
revised: 12 04 2023
accepted: 12 04 2023
medline: 22 5 2023
pubmed: 22 4 2023
entrez: 21 04 2023
Statut: ppublish

Résumé

Diabetic kidney disease (DKD) increases the risk of cardiovascular (CV) complications, kidney disease progression, and mortality. We aimed to determine the incidence and risk of these outcomes according to DKD phenotype among the Jordanian population. A total of 1172 type 2 diabetes mellitus patients with estimated glomerular filtration rates (eGFRs) of >30 ml/min/1.73 m Mean follow-up was 2.9 ± 0.4 years. Overall, 147 patients (12.5 %) experienced CV events, while 61 (5.2 %) demonstrated kidney disease progression (eGFR: <30 ml/min/1.73 m Thus, patients with albuminuric DKD and decreased eGFR were at greater risk for poor CV, renal, and mortality outcomes compared to other phenotypes.

Sections du résumé

BACKGROUND
Diabetic kidney disease (DKD) increases the risk of cardiovascular (CV) complications, kidney disease progression, and mortality. We aimed to determine the incidence and risk of these outcomes according to DKD phenotype among the Jordanian population.
METHODS
A total of 1172 type 2 diabetes mellitus patients with estimated glomerular filtration rates (eGFRs) of >30 ml/min/1.73 m
RESULTS
Mean follow-up was 2.9 ± 0.4 years. Overall, 147 patients (12.5 %) experienced CV events, while 61 (5.2 %) demonstrated kidney disease progression (eGFR: <30 ml/min/1.73 m
CONCLUSION
Thus, patients with albuminuric DKD and decreased eGFR were at greater risk for poor CV, renal, and mortality outcomes compared to other phenotypes.

Identifiants

pubmed: 37084653
pii: S1056-8727(23)00076-4
doi: 10.1016/j.jdiacomp.2023.108478
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108478

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflicts of interest.

Auteurs

Randa Farah (R)

Nephrology Division, Department of Internal Medicine, School of Medicine, University of Jordan, Amman, Jordan. Electronic address: r.farah@ju.edu.jo.

Abdulrahman Alhajahjeh (A)

School of Medicine, University of Jordan, Amman, Jordan.

Amani Nofal (A)

School of Medicine, University of Jordan, Amman, Jordan.

Tala Basheer Hyasat (TB)

School of Medicine, University of Jordan, Amman, Jordan.

Raghed Abdel Hay Abu Jabeh (RAH)

School of Medicine, University of Jordan, Amman, Jordan.

Lojayn Tareq Suboh (LT)

School of Medicine, University of Jordan, Amman, Jordan.

Hussam Alhawari (H)

Endocrinology Division, Department of Internal Medicine, School of Medicine, University of Jordan, Amman, Jordan.

Munther S Momani (MS)

Endocrinology Division, Department of Internal Medicine, School of Medicine, University of Jordan, Amman, Jordan.

Hazem Jamal Jaber (HJ)

Department of Internal Medicine, School of Medicine, University of Jordan, Amman, Jordan.

Izzat AlAwwa (I)

Nephrology Division, Department of Internal Medicine, School of Medicine, University of Jordan, Amman, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH